NTLA vs. AAPL
Compare and contrast key facts about Intellia Therapeutics, Inc. (NTLA) and Apple Inc (AAPL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTLA or AAPL.
Correlation
The correlation between NTLA and AAPL is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NTLA vs. AAPL - Performance Comparison
Key characteristics
NTLA:
-0.87
AAPL:
0.27
NTLA:
-1.43
AAPL:
0.63
NTLA:
0.84
AAPL:
1.09
NTLA:
-0.67
AAPL:
0.28
NTLA:
-1.43
AAPL:
0.95
NTLA:
45.68%
AAPL:
9.69%
NTLA:
73.44%
AAPL:
32.34%
NTLA:
-96.45%
AAPL:
-81.80%
NTLA:
-95.32%
AAPL:
-23.67%
Fundamentals
NTLA:
$915.67M
AAPL:
$2.97T
NTLA:
-$5.25
AAPL:
$6.43
NTLA:
-0.10
AAPL:
2.02
NTLA:
15.46
AAPL:
7.66
NTLA:
1.03
AAPL:
45.92
NTLA:
$28.94M
AAPL:
$400.37B
NTLA:
$23.78M
AAPL:
$186.70B
NTLA:
-$412.49M
AAPL:
$138.87B
Returns By Period
In the year-to-date period, NTLA achieves a -28.99% return, which is significantly lower than AAPL's -21.05% return.
NTLA
-28.99%
31.85%
-48.25%
-64.00%
-9.53%
N/A
AAPL
-21.05%
14.54%
-12.99%
8.58%
21.29%
21.49%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTLA vs. AAPL — Risk-Adjusted Performance Rank
NTLA
AAPL
NTLA vs. AAPL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTLA vs. AAPL - Dividend Comparison
NTLA has not paid dividends to shareholders, while AAPL's dividend yield for the trailing twelve months is around 0.51%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTLA Intellia Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AAPL Apple Inc | 0.51% | 0.40% | 0.49% | 0.70% | 0.49% | 0.61% | 1.04% | 1.79% | 1.45% | 1.93% | 1.93% | 1.67% |
Drawdowns
NTLA vs. AAPL - Drawdown Comparison
The maximum NTLA drawdown since its inception was -96.45%, which is greater than AAPL's maximum drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for NTLA and AAPL. For additional features, visit the drawdowns tool.
Volatility
NTLA vs. AAPL - Volatility Comparison
Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 30.95% compared to Apple Inc (AAPL) at 17.85%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTLA vs. AAPL - Financials Comparison
This section allows you to compare key financial metrics between Intellia Therapeutics, Inc. and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities